Methods for treating retroviral infections

Details Methods for treating retroviral infections Methods for treating retroviral infections

2005-04-22

2009-12-01

Wang, Shengjun (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

C514S602000, C514S603000, C514S617000, C514S183000, C514S252100, C514S277000, C514S334000, C514S344000, C514S345000, C514S415000, C514S422000, C514S423000, C514S424000, C514S425000, C514S426000, C514S427000

Reexamination Certificate

active

07625949

ABSTRACT:
The present invention provides compounds for treating or preventing an HIV infection, or treating AIDS or ARC comprising administering a compound according to formula I where Ar, R1-R5, R11cand X1are as defined herein.

REFERENCES:
patent: 6028080 (2000-02-01), Ackermann et al.
patent: 6710205 (2004-03-01), Tani et al.
patent: 2003/0114435 (2003-06-01), Tani et al.
patent: 2003/0187068 (2003-10-01), Miyachi et al.
patent: 2003/0220241 (2003-11-01), Defeo-Jones et al.
patent: 2-218654 (1990-08-01), None
patent: WO 92/00952 (1992-01-01), None
patent: WO 93/15043 (1993-08-01), None
patent: WO 96/22990 (1996-08-01), None
patent: WO 97/26244 (1997-07-01), None
patent: WO 98/50346 (1998-11-01), None
patent: WO 99/17777 (1999-04-01), None
patent: WO 99/55663 (1999-11-01), None
patent: WO 99/65874 (1999-12-01), None
patent: WO 00/64876 (2000-11-01), None
patent: WO 01/17982 (2001-03-01), None
patent: WO 01/19788 (2001-03-01), None
patent: WO 01/21596 (2001-03-01), None
patent: WO 01/64642 (2001-09-01), None
patent: WO 02/057236 (2002-07-01), None
patent: WO 02/070494 (2002-09-01), None
Milton et al. Biaryl acids: Novel non-nucleoside inhibitors of HIV reverse transcriptase types 1 and 2, Bioorganic & Medicinal Chemistry Letters, 1998, vol. 8, pp. 2623,2628.
W. Buckheit, Jr., Non-nucleoside reverse transcriptase inhibitors: perspectives for novel therapeutic compounds and strategies for treatment of HIV infection,Expert Opin. Investig.Drugs 2001 10(8):1423-1442.
R. W. Carling et al., 4-Substituted-3-phenylquinolin-2(1H)-ones: Acidic and Nonacidic Glycine Site N-Methyl-D-aspartate Antagonists with in Vivo Activity,J. Med. Chem., 1997 40:754-765.
J. H. Chan et al., Novel Benzophenones as Non-nucleoside Reverse Transciptase Inhibitors of HIV-1.J. Med Chem.2004 47(5):1175-1182.
E. De Clercq, New Developments in Anti-HIV Chemotherap.Curr. Med. Chem. 2001 8:1543-1572.
M. C. Iles et al., Carbonic Anhydrase Inhibitors. Inhibition of Tumor-Associated Isozyme IX by Halogenosulfanilamide and Halogenophenylaminobenzolamide Derivatives,J. Med. Chem. 2003 46(11):2187-2196.
A. Kreimeyer et al., Evaluation and Biological Properties of Reactive Ligands for the Mapping of the Glycine Site on the N-Methyl-D-aspartate (NMDA) Receptor,J. Med. Chem. 1999 42:4394-4404.
J. J. Kulagowski et al., 3′-(Arylmethyl)- and 3′-(Aryloxy)-3-phenyl-4-hydroxyquinolin- 2(1H)-ones: Orally Active Antagonists of the Glycine Site on the NMDA Receptor,J. Med. Chem. 1994 37:1402-1405.
M. Rowley et al., Effect of Plasma Protein Binding on in Vivo Activity and Brain Penetration of Glycine/NMDA Receptor Antagonists,J. Med. Chem. 1997 40:4053-4068.
P. G. Wyatt et al., Benzophenone Derivatives: A Novel Series of Potent and Selective Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase,J. Med. Chem. 1995 38(10):1657-1665).

Affiliated with

Also associated with

Rating

Methods for treating retroviral infections does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for treating retroviral infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating retroviral infections will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4130039